Recent advancement in prodrugs /
Recent Advancement in Prodrugs Drugs used as medicines have many limitations like low chemical stability, aqueous solubility, or oral absorption/bioavailability, rapid presystemic metabolism, toxicity, inadequate site specificity, or poor patient acceptance/compliance (unwanted adverse effects, unac...
Saved in:
Other Authors: | , , , |
---|---|
Format: | Electronic eBook |
Language: | English |
Published: |
Boca Raton, FL :
CRC Press,
2020.
|
Edition: | First edition. |
Subjects: | |
Online Access: | Taylor & Francis OCLC metadata license agreement |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000cam a2200000Ki 4500 | ||
---|---|---|---|
001 | 9780429328275 | ||
003 | FlBoTFG | ||
005 | 20230120124305.0 | ||
006 | m o d | ||
007 | cr cnu---unuuu | ||
008 | 200524t20202020flua ob 001 0 eng d | ||
040 | |a OCoLC-P |b eng |e rda |c OCoLC-P | ||
020 | |a 9781000057973 |q electronic book | ||
020 | |a 1000057976 |q electronic book | ||
020 | |a 9780429328275 |q electronic book | ||
020 | |a 0429328273 |q electronic book | ||
020 | |a 9781000057997 |q electronic book |q EPUB | ||
020 | |a 1000057992 |q electronic book |q EPUB | ||
020 | |z 0367348365 | ||
020 | |z 9780367348366 | ||
035 | |a (OCoLC)1155215954 | ||
035 | |a (OCoLC-P)1155215954 | ||
050 | 4 | |a RM301.57 |b .R43 2020 | |
072 | 7 | |a SCI |x 013020 |2 bisacsh | |
072 | 7 | |a TDCW |2 bicssc | |
082 | 0 | 4 | |a 615.19 |2 23 |
245 | 0 | 0 | |a Recent advancement in prodrugs / |c edited by Kamal Shah, Durgesh Nandini Chauhan, Nagendra Singh Chauhan, Pradeep Mishra. |
250 | |a First edition. | ||
264 | 1 | |a Boca Raton, FL : |b CRC Press, |c 2020. | |
264 | 4 | |c ©2020 | |
300 | |a 1 online resource (xiii, 335 pages) : |b illustrations | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
520 | |a Recent Advancement in Prodrugs Drugs used as medicines have many limitations like low chemical stability, aqueous solubility, or oral absorption/bioavailability, rapid presystemic metabolism, toxicity, inadequate site specificity, or poor patient acceptance/compliance (unwanted adverse effects, unacceptable taste or odor, irritation or pain). Prodrugs design is an approach to overcome these limitations. Key features Covers recent advancements in development of prodrugs Presents balanced synthesis and applications of prodrug chemistry Discusses broad spectrum of prodrug categories and outlines industrial applications Reviews prodrugs in cancer nanomedicine, its therapy and treatment Elucidates mathematical models to study the kinetics of prodrugs This book covers recent advances in the design of prodrugs. It contains all the significant recent examples of prodrug chemistry developments and will aid academics and researchers seeking to generate new projects in the field. | ||
588 | |a OCLC-licensed vendor bibliographic record. | ||
650 | 0 | |a Prodrugs. |9 20685 | |
650 | 7 | |a SCIENCE / Chemistry / Clinical |2 bisacsh |9 20686 | |
700 | 1 | |a Shah, Kamal, |e editor. |9 20687 | |
700 | 1 | |a Chauhan, Durgesh Nandini, |e editor. |9 20688 | |
700 | 1 | |a Chauhan, Nagendra Singh, |e editor. |9 20689 | |
700 | 1 | |a Mishra, Pradeep, |e editor. |9 20690 | |
856 | 4 | 0 | |3 Taylor & Francis |u https://www.taylorfrancis.com/books/9780429328275 |
856 | 4 | 2 | |3 OCLC metadata license agreement |u http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf |
999 | |c 205599 |d 205598 |